相关实验视频
Updated: Jul 17, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
测量白蛋白尿或蛋白尿:一个答案是否适合所有?
Tyrone G Harrison1, Marcello Tonelli1
1Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
选择最好的蛋白尿检测测试,如专尿,是病管理的关键. 指南建议使用白蛋白与肌素的比例,但其可用性,成本和准确性各不相同,影响了临床决策.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床化学 临床化学
背景情况:
- 精确测量蛋白尿是诊断和监测病的必要条件.
- 存在各种方法来测量总蛋白尿或白蛋白尿,使用随机或定时尿液收集.
研究的目的:
- 审查有关蛋白尿尿量测量的国际指南.
- 讨论最佳措施不清楚或有争议的情况,包括特定的临床环境.
主要方法:
- 审查国际指导方针和支持证据.
- 讨论影响蛋白尿测量选择的因素.
主要成果:
- 尿中的白蛋白与肌素的比率是国际上推的,但并非普遍可用或始终具有成本效益.
- 不同测量的准确性可以根据albuminuria水平,患者的性别和临床背景而有所不同.
结论:
- 最佳选择蛋白尿测量需要考虑指南建议,可用性,成本和特定患者因素.
- 临床背景,如血球膜炎,移植和怀孕,在选择适当的蛋白尿检测中提出了独特的挑战.
更多相关视频
09:16Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
Published on: August 9, 2019
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
Serum Studies: Renal Function Tests
Urine Studies I: Urinalysis
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease III: Interprofessional Care